Targeting Channelrhodopsin-2 to ON-bipolar Cells With Vitreally Administered AAV Restores ON and OFF Visual Responses in Blind Mice
Citations Over TimeTop 10% of 2014 papers
Abstract
Most inherited retinal dystrophies display progressive photoreceptor cell degeneration leading to severe visual impairment. Optogenetic reactivation of retinal neurons mediated by adeno-associated virus (AAV) gene therapy has the potential to restore vision regardless of patient-specific mutations. The challenge for clinical translatability is to restore a vision as close to natural vision as possible, while using a surgically safe delivery route for the fragile degenerated retina. To preserve the visual processing of the inner retina, we targeted ON bipolar cells, which are still present at late stages of disease. For safe gene delivery, we used a recently engineered AAV variant that can transduce the bipolar cells after injection into the eye's easily accessible vitreous humor. We show that AAV encoding channelrhodopsin under the ON bipolar cell-specific promoter mediates long-term gene delivery restricted to ON-bipolar cells after intravitreal administration. Channelrhodopsin expression in ON bipolar cells leads to restoration of ON and OFF responses at the retinal and cortical levels. Moreover, light-induced locomotory behavior is restored in treated blind mice. Our results support the clinical relevance of a minimally invasive AAV-mediated optogenetic therapy for visual restoration.
Related Papers
- → Optogenetic identification of striatal projection neuron subtypes during in vivo recordings(2012)110 cited
- → WONOEP appraisal: Optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis(2014)21 cited
- [Mind control with optogenetic mice: exploring the causal relationships between brain activity and the mind].(2013)
- → Transcranial optogenetic stimulation for mapping of the motor cortex(2009)1 cited
- [Optogenetic analysis of striatal circuits].(2012)